2 studies found for:    18971421 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Phase II Trial of TIL Following CCRT in Patients With Locoregionally Advanced NPC
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Cisplatin+TIL;   Drug: Cisplatin
2 Completed EBV-Specific CTLs Following CD45 Antibody to Patients With Epstein-Barr Virus (EBV) + Nasopharyngeal Carcinoma (NPC)
Conditions: Nasopharyngeal Cancer;   EBV Infections
Interventions: Biological: EBV specific CTL Infusion;   Biological: Anti CD45 monoclonal antibody

Indicates status has not been verified in more than two years